Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

724 ARTÍCULOS , VIENDO DEL 631 AL 645

Sleep disorder assessment in children and adolescents with neurodevelopmental disorders

El Halal CDS, Nunes ML.

J Pediatr (Rio J). 2026 Mar-Apr;102 Suppl 1(Suppl 1):101441. doi: 10.1016/j.jped.2025.101441. Epub 2025 Sep 26.

From rodents to algorithms: The rise of virtual animals in drug development and neuroscience

Minagar A, Sahraian MA.

Clin Neurol Neurosurg. 2026 Jan;260:109234. doi: 10.1016/j.clineuro.2025.109234. Epub 2025 Nov 9.

Navigating the assessment of sleep-related bruxism: Clinical guidance for applying the 2023 ICSD-3-TR criteria

Herrero Babiloni A, Lavigne GJ, Svensson P, Dal Fabbro C, Carra MC.

Sleep Med. 2026 Jan;137:106891. doi: 10.1016/j.sleep.2025.106891. Epub 2025 Nov 1.

An updated overview on clinical and developmental trajectories of developmental and epileptic encephalopathies: From childhood to adulthood

Mastrangelo M, Bonaventura CD, Lentini G, Pisani F.

Seizure. 2026 Jan;134:190-197. doi: 10.1016/j.seizure.2025.12.009. Epub 2025 Dec 16.

Emergent technologies and applications of TMS and TMS-EEG in clinical neurophysiology for early and differential diagnosis: IFCN handbook chapter

Benussi A, Vucic S.

Clin Neurophysiol. 2026 Jan;182:2111459. doi: 10.1016/j.clinph.2025.2111459. Epub 2025 Nov 26.

Evaluating the adenosine hypothesis of restless legs syndrome and its implications for current and future treatment strategies

Mogavero MP, Lanza G, Quercia A, Palmigiano A, Bruni O, Ferri R.

Expert Rev Neurother. 2026 Feb;26(2):125-134. doi: 10.1080/14737175.2025.2603544. Epub 2025 Dec 17.

A European perspective on tardive dyskinesia

Colosimo C, Jain R, Duma K, Kurzeja A, Arango C.

Eur Neuropsychopharmacol. 2026 Mar;104:112740. doi: 10.1016/j.euroneuro.2025.11.017. Epub 2025 Dec 19.

A novel heterozygous variant of FUS gene associated with juvenile ALS and premature tremor onset: a case report

Rodríguez-García V, Venta-Sobero JA, Chima-Galán MDC.

Amyotroph Lateral Scler Frontotemporal Degener. 2026 Feb;27(1-2):230-232. doi: 10.1080/21678421.2025.2522403. Epub 2025 Jun 22.

Paroxysmal Dyskinesia with a Novel Variant in the Histone 3 Family 3B (H3-3B) Gene

D'Onofrio G, Perreault S, Mitchell G, Meijer IA.

Mov Disord Clin Pract. 2026 Jan;13(1):269-271. doi: 10.1002/mdc3.70236. Epub 2025 Jul 22.

ACTH-Induced Dyskinesia Mimics Autoimmune Encephalitis: A Case Report with Literature Review

Bektaş Öntaş H, Baştemur M, Haliloğlu G.

Mov Disord Clin Pract. 2026 Apr;13(4):1076-1079. doi: 10.1002/mdc3.70414. Epub 2025 Oct 23.

Lingual Dyskinesia Developing after the First Dose of Methylphenidate Treatment in a Child with Neurodevelopmental Disorders: Genetic Predispositions

Karagöz D, Kurt HİZ, Şahin N.

Clin Psychopharmacol Neurosci. 2026 Feb 28;24(1):197-201. doi: 10.9758/cpn.25.1317. Epub 2025 Sep 11.

Reply to: "Moving Forward in Movement Disorders: The Need for Studies on Environmental Triggers"

Harder-Rauschenberger L, Ip CW.

Mov Disord. 2026 Feb;41(2):553-554. doi: 10.1002/mds.70172. Epub 2025 Dec 29.

Moving Toes Syndrome in Children and Youth: Case Series of a Rare Disorder

Doja A, Tripathi R, Scarisbrick D, Kimble W, Soliani L, Pugliano R, Cordelli DM, Bergonzini L.

J Child Neurol. 2026 May;41(5):743-746. doi: 10.1177/08830738251383179. Epub 2025 Oct 21.

Minimizing Botulinum Toxin Wastage: Insights From a Movement Disorders Practice

Hameed S, Shah B, Higinbotham A, Dalrymple WA, Figari-Jordan R.

Mov Disord Clin Pract. 2026 Mar;13(3):841-842. doi: 10.1002/mdc3.70421. Epub 2025 Oct 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias